News • Quicker diagnosis approach
New biosensor for detecting active tuberculosis
A research team is leading the development of a sensor that paves the way for the rapid, selective and cost-effective detection of active tuberculosis infection.
Search for: "tuberculosis" - 140 articles found
News • Disease tolerance and infection pathogenesis
Different age, same infection treatment? Not a good idea, study finds
Should younger and older people receive different treatments for the same infection? New research suggests that age-specific treatments may be necessary in ongoing antibiotic resistance crisis.
News • Global rise in infectious diseases
'Creeping catastrophe': New study warns of health impact of climate change
Climate change, poverty, and drug resistance are combining to create an escalating health crisis that could become a ‘creeping catastrophe’ if left unaddressed, a new international study finds.
News • Environmental impact
Plastic waste from test kits: call for urgent action
During the Covid-19 pandemic, everyone became familiar with lateral flow tests. These tests generate a lot of plastic waste, creating an environmental crisis. Experts call for urgent action.
News • HIV, TB, viral hepatitis, STIs
Europe not on track to reach 2030 health goals
Ending epidemics like HIV, tuberculosis, hepatitis and STIs by 2030 is a key health goal for Europe. Although progress has been made, many EU countries are not on track to meet the goals, experts say.
News • Sputum-free, rapid alternative for TB detection
POCT AI-guided lung ultrasound boosts tuberculosis diagnosis
Despite previous global declines, pulmonary tuberculosis (TB) is on the rise again. A new AI-powered lung ultrasound shows promise in improving diagnostic performance of TB.
News • HBV point-of-care identification
Hepatitis B: rapid diagnostic test to halt mother-to-child transmission
A new rapid diagnostic test can identify pregnant women at elevated risk of transmitting hepatitis B to their babies. This could help prevent mother-to-child transmission during childbirth.
News • 2025 TB surveillance and monitoring report
Childhood tuberculosis up by 10%: a wake-up call for Europe
Transmission of tuberculosis (TB) in the European Region is still ongoing, and immediate public health measures are needed to control and reduce the growing burden of the disease, experts urge.
News • Therapy innovation
Four advances that could change tuberculosis treatment
World TB Day raises awareness about tuberculosis and commemorates the discovery of the source bacterium M. tuberculosis. More than a century later, scientists still refine anti-TB strategies.
News • Immunology
“One and done”: promise for a universal influenza vaccine
New research reveals a promising approach to developing a universal influenza vaccine that confers lifetime immunity against an evolving virus considered most likely to trigger the next pandemic.
News • Tracking the spread and evolution of superbugs
Mapping the movement of people (and their pathogen travel companions)
Integrating bacterial genomic data with detailed human mobility data makes it possible to see how pathogens causing pneumonia and meningitis, move between regions and evolve over time.
News • Specific TB scan
PET imaging shows tuberculosis in the body
A new radiotracer enables positron emission tomography (PET) scans to be used for the first time to accurately pinpoint when and where tuberculosis (TB) is still active in a patient’s lungs.
News • Novel treatment strategy
Antibacterial nanoparticles to shorten tuberculosis therapy duration
A low-cost technology involving nano-sized antimicrobial compounds against tuberculosis has been developed by researchers at São Paulo State University (UNESP).
News • Unexpected behaviour
Pathogens can force their way through the immune defense, new study shows
Breaking & entering – on a minuscule scale: US researchers have shown how some pathogens like Toxoplasma can enter cells using physical force to cause an infection.
News • Sustainability in healthcare
Creating a circular economy for medical testing plastics
Global healthcare consumes millions of tonnes of single use plastic every year. A team at the University of Birmingham is taking on this sustainability challenge.
News • Chest x-ray analysis
Lung cancer: High accuracy AI improves detection
Assistance from an AI algorithm with high diagnostic accuracy improved radiologist performance in detecting lung cancers on chest X-rays and increased human acceptance of AI suggestions.
News • Antibacterial compound research
Developing antibiotics that target multiple-drug-resistant bacteria
Researchers have designed and synthesized analogs of a new antibiotic that is effective against multidrug-resistant bacteria, opening a new front in the fight against these infections.
News • Appeal for sustainability
POCT: Why the medical sector must tackle its single-use diagnostic waste
During the Covid-19 pandemic, the use of these single-use diagnostics, or point-of-care tests has exploded. This is having major environmental consequences, experts point out.
Sponsored • Covid-19 management
Rapid and robust PCR testing for infectious diseases at Innklinikum Altötting and Mühldorf
The Covid-19 pandemic has highlighted the importance of the fast and accurate diagnosis of infectious diseases in clinical settings. Harald Maier discusses the implementation of rapid molecular diagnostics in the central clinical diagnostics laboratory at Innklinikum Altötting and Mühldorf, highlighting how the use of PCR testing has benefitted the hospital during the Covid-19 pandemic.
Article • Current and emerging imaging applications
Challenges of AI in chest radiography
Physicians use AI-powered technology for faster and earlier detection of diseases. At ECR Overture, Dr Steven Schalekamp, PhD, discussed the application of AI for chest radiography in paediatrics.
News • Elusive variants
Rare genetic markers of drug-resistant tuberculosis identified
The search for rare mutations in bacterial genome could lead to better diagnostics and treatments – reducing morbidity caused by the deadly disease.
News • Alternative to injection
Inhaled vaccine delivers broad protection against SARS-CoV-2
Scientists have confirmed that an inhaled form of COVID vaccine can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
News • 'CRyPTIC' research
Global tuberculosis study identifies genetic causes of drug resistance
Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments. The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has collected the largest ever global dataset of clinical M.…
News • Combined with antibiotics
Bacteria-killing viruses to fight antibiotic-resistant bacteria
Researchers have found a way to defeat the multi-resistant bacterium Mycobacterium abscessus, a relative of the causes of tuberculosis and leprosy.
News • TB drug development cooperation
Unite4TB: A new era in Tuberculosis treatment development
To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. The 7-year, €185 million project called Unite4TB, aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs, with the goal of developing…
News • Deep learning vs Aids
AI app could help diagnose HIV more accurately
Pioneering technology developed by University College London (UCL) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries. Academics from the London Centre for Nanotechnology at UCL and AHRI used deep learning (artificial intelligence/AI) algorithms to improve health workers’…
News • „Swarm Learning“
AI with swarm intelligence to analyse medical data
Communities benefit from sharing knowledge and experience among their members. Following a similar principle - called “swarm learning” - an international research team has trained artificial intelligence algorithms to detect blood cancer, lung diseases and Covid-19 in data stored in a decentralized fashion. This approach has advantage over conventional methods since it inherently provides…
News • Bioorganic chemistry
Why M. tuberculosis is so resistant to drugs and immune defenses
A consortium of researchers from Russia, Belarus, Japan, Germany and France led by the Skolkovo Institute of Science and Technology have uncovered the way in which Mycobacterium tuberculosis survives in iron-deficient conditions by utilizing rubredoxin B, a protein from a rubredoxin family that play an important role in adaptation to changing environmental conditions.
Sponsored • Radiology collaboration
Improved workflow and a touch of Disney magic
Improving workflow is one of the major challenges that radiology departments face. The need to be more efficient, deliver timely and effective patient care, and keep an eye on costs are all factors that seem to be ever-present in the modern imaging department. With the added demands of the coronavirus pandemic as radiology departments continue to play a critical role in the fight against…
News • Immune response or breast cancer?
Swollen lymph nodes after Covid-19 vaccination: what women should know
For many women, swollen lymph nodes are a red flag pointing to breast cancer – but may also be a normal immune reaction to a Covid-19 vaccination. In this Q&A, breast imaging experts address the most important facts on the topic.
News • Study from Zambia shows many more deaths
Experts: Impact of Covid-19 in Africa “vastly underestimated”
The impact of Covid-19 in Africa has been vastly underestimated, warn researchers in a new study. Outside of South Africa, this is the first study to provide systematic surveillance data capturing the impact of Covid-19 in Africa. Their findings are based on polymerase chain reaction (PCR) test results for 364 deceased people of all ages at the University Teaching Hospital morgue in Lusaka,…
News • TB test shows promise
New method to assist fast-tracking of vaccines
With Covid-19 dominating medical science and human concern, chemists at the University of Sydney have developed a method to quickly and safely synthesise protein vaccines for respiratory diseases for pre-clinical tests. Their approach can be used to test vaccine strategies against novel pandemic pathogens such as SARS-CoV-2, the virus that causes Covid-19.
News • "Faces" of the disease
Covid-19: researchers identify at least 5 variants
According to current studies, the Covid-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants. These differ in how the immune system responds to the infection. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, together with other experts from Germany, Greece and the Netherlands, present these findings…
Video • Correlative light, electron and ion microscopy in tissue
New imaging method reveals bacteria hiding from antibiotics
Researchers at the Francis Crick Institute and the University of Western Australia have developed a new imaging method to see where antibiotics have reached bacteria within tissues. The method could be used to help develop more effective antibiotic treatments, reducing the risk of antibiotic resistance.
Article • The role of chest CT in diagnosis and treatment
UPDATE: Covid-19 and lung infections imaging
RSNA 2020: International experts showcased new studies on chest CT’s role in Covid-19 diagnosis and treatment. A staggering volume of work and has been produced on the pandemic this year, with an average 367 Covid-19 journal articles published per week, according to Michael Chung, Assistant professor of radiology at Icahn School of Medicine at Mount Sinai, NYC.
News • Solving a mystery
How the TB bacterium develops rapid resistance to antibiotics
For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.
Article • Report
Focused Ultrasound: 60,000+ patients worldwide received treatments
The Focused Ultrasound Foundation (FUS) has published its 2020 State of the Field Report, a 63-page annual update detailing new potential indications, laboratory research, clinical trials, treatments and growth in worldwide procedures performed in 2019.
News • Using virus particles in exhaled breath
New SARS-CoV-2 test to deliver results in under 5 minutes
Research and innovation hub Imec announced that it has started developing a groundbreaking SARS-CoV-2 test. Unlike current approaches (using blood, saliva, or a nasopharyngeal swab), the new test will identify SARS-CoV-2 virus particles in a person’s exhaled breath. The solution promises the accurate identification of a contagious case in less than five minutes.
Video • For breakthroughs against Hepatitis C
Nobel Prize in Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Rice
The 2020 Nobel Prize in Medicine is awarded to three scientists who have made a decisive contribution to the fight against blood-borne hepatitis, a major global health problem that causes cirrhosis and liver cancer in people around the world. Harvey J. Alter, Michael Houghton and Charles M. Rice made seminal discoveries that led to the identification of a novel virus, Hepatitis C virus.
News • Immune system
Tuberculosis vaccine also makes less susceptible to other infections
A tuberculosis vaccine developed 100 years ago also makes vaccinated persons less susceptible to other infections. While this effect has been recognized for a long time, it is not known what causes it. Together with colleagues from Australia and Denmark, researchers from Radboud university medical center the universities of Nijmegen and Bonn have now presented a possible answer to this question.
News • Teixobactin against superbugs
Researchers find 'resistance resistant' antibiotic
University of Melbourne researchers are finding ways to beat dangerous superbugs with ‘resistance resistant’ antibiotics, and it could help in the fight against coronavirus (COVID-19) complications. As bacteria evolve, they develop strategies that undermine antibiotics and morph into ‘superbugs’ that can resist most available treatments and cause potentially lethal infections. The…
News • Coronavirus duration questioned
COVID-19 symptoms disappear – while the virus itself remains
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
News • BCG vs tumour recurrence
Modified tuberculosis vaccine shows promise against bladder cancer
The human immune system can recognize and eliminate not only germs but also cancer cells. This is why treatments with weakened germs can help the immune system in its fight against cancer. Researchers at the Max Planck Institute for Infection Biology in Berlin have genetically modified the tuberculosis vaccine BCG in a way that it stimulates the immune system more specifically. Consequently, the…
News • Development of a highly sensitive analytical workflow
Collaboration for infectious disease diagnosis and patient monitoring
Thermo Fisher Scientific and NanoPin Technologies, Inc. have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows. Through the detection of disease-related antigens directly from patient blood samples, NanoPin's unique diagnostic platform…
Article • Where are the infectiologists?
‘The hygiene plan is nothing but a fig leaf’
Nosocomial infections cause more deaths than traffic accidents – a stunning discovery made in a recent German study. Worse: infectious diseases long thought eradicated in Europe, such as measles, tuberculosis (TB) and, more recently, syphilis, are also implicated. The increasing number of patients places an additional financial burden on healthcare. But – and this might be the good news –…
News • Epidemiology
Tuberculosis: A quarter of the world's population at risk
A new study from Aarhus University Hospital and Aarhus University has shown that probably 1 in 4 people in the world carry the tuberculosis bacterium in the body. The disease tuberculosis is caused by the bacterium Mycobacterium Tuberculosis, which affects more than 10 million people every year, and kills up to 2 million, making it the most deadly of the infectious diseases.
News • Global health
WHO updates list of essential medicines and diagnostics
The World Health Organisation's (WHO) Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. Now, updated versions of the two lists have been published, focusing on cancer and other global health challenges, with an emphasis on effective…
Article • Detecting migrant health risks
‘Refugees do not bring diseases to western shores’
The migrant population is fast growing and heterogeneous. Experts at a session held during the European Congress of Radiology (ECR 2019) concluded that radiologists can play a key role in detecting and differentiating related diseases. Migration is a growing phenomenon and has an impact on health, according to Jozef Bartovic from the World Health Organisation (WHO) in Copenhagen, Denmark.…
News • Surprising similarities
These are the top 25 medical lab tests around the world
A recent study can help governments understand which diagnostic laboratory tests are most important when developing universal health coverage systems. Researchers from five countries found that diagnostic laboratory tests are used similarly around the world, even though the institutions they studied differed in terms of poverty levels, health systems and prevalence of disease. “Even though…
News • Survival of the fittest
How bacteria can adapt to resist antibiotic treatment
In a joint collaboration, researchers from Denmark and Switzerland have shown that bacteria produce a specific stress molecule, divide more slowly, and thus save energy when they are exposed to antibiotics. The new knowledge is expected to form the basis for development of a new type of antibiotics. All free-living organisms are under constant pressure to survive. Darwin dubbed this…
News • Tuberculosis
So did drug resistant TB evolve and spread globally
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute of Public Health.
News • AACC Disruptive Technology Award
Developers take diagnostics to the patient
Over the last several years, technological advancements have enabled the development of tests that can be performed right where the patient is, whether that’s in a hospital room, primary care office, or community health center. This is a paradigm shift in healthcare delivery that will make it easier for patients to get accurate diagnoses and treatment, and could especially benefit patients in…
News • Air disinfection and purification device
Closing the infection control loop
Novaerus, an Irish company specialising in non-chemical air disinfection using patented ultra-low energy plasma, announced the launch of the Defend 1050, a portable, easy to use device ideal for rapid disinfection and purification of the air in large spaces and high-risk situations such as operating theatres, ICUs, IVF labs, emergency and waiting rooms, and construction zones.
News • New function assessment
Measuring immune cell response within minutes
T cells fight pathogens and tumors: Researchers from the Universities of Tübingen and Lübeck present a simple and fast method to rapidly assess their function. Due to its simplicity, reliability and versatility, it could be broadly implemented for basic research and in the clinical setting. Methods so far to test T-cell response were technically cumbersome and time-consuming and therefore only…
News • Infections
Tuberculosis: new substance to counteract antimicrobial resistance
Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists at Martin Luther University Halle-Wittenberg (MLU) have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it. The…
Article • The impact of AI
Radiology and radiologists: a painful divorce
AI-based applications will replace radiologists in some areas, the physicist Bram van Ginneken predicts. ‘The profession of radiologist will change profoundly,’ predicts Gram van Ginneken, Professor of Medical Image Analysis at Radboud University Medical Centre. The cause is automatic image analysis by computers (first published in a paper in 1963) and deep learning.
News • Tuberculosis
New blood test predicts TB onset up to two years in advance
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB, according to research published online in the American Journal of Respiratory and Critical Care Medicine, an American Thoracic Society journal. Those living with someone with active TB are at highest risk for developing the…
Sponsored • A discipline transforming
Adding value with AI in medical imaging
In the next five to 10 years, artificial intelligence is likely to fundamentally transform diagnostic imaging. This will by no means replace radiologists, but rather help to meet the rising demand for imaging examinations, prevent diagnostic errors, and enable sustained productivity increases.
News • New data
WHO: High levels of antibiotic resistance found worldwide
WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries. WHO’s new Global Antimicrobial Surveillance System (GLASS) reveals widespread occurrence of antibiotic resistance among 500 000 people with suspected bacterial infections across 22 countries.
News • Infectious disease
One in two people living with HIV in Europe is diagnosed late
The WHO European Region is the only region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic Area (EU/EEA), this trend continued in 2016. One reason for this worrying trend: over half (51%) of the reported HIV diagnoses happen in a…
News • Clinical trial
A simple breath test could evolve breast cancer diagnostics
The University of Southern California (USC) Norris Comprehensive Cancer Center is actively recruiting for a clinical trial that is researching the effectiveness of a breath test for breast cancer diagnostics. The BreathLink device, manufactured by Menssana Research, Inc., captures a two-minute sample of a patient’s breath and provides immediate results on whether there are indications of breast…
News • Strategic cooperation
SpeeDx and Cepheid announce partnership on European distribution
SpeeDx Pty, Ltd. announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for…
News • Multidrug-resistant TB
Another facet to the migration crisis in Europe
Multidrug-resistant tuberculosis (MDR-TB) is widespread globally, with an estimated 480,000 cases in 2014.Although rare in European countries, the risks posed by the current migrant crisis makes MDR-TB an important and urgent public health priority.
Article • Drug delivery
Biotherapeutics strike cancer cell growth
Many drug treatments do not work due to their poor ability to reach their intended targets inside patients’ cells. To address this, researchers at Cardiff University’s Schools of Pharmacy and Pharmaceutical Sciences, and Biosciences have designed a highly efficient method to improve the delivery of therapeutic molecules into diseased cells such as those in stomach cancer, breast cancer and…
Article • Disaster areas
Winners on the firing line
Jens Hahn MD is an Internal Medicine and Intensive Care Specialist who works with the international, independent, medical humanitarian organisation Médecins Sans Frontières (MSF in English: Doctors Without Borders). Here he describes his work in Afghanistan and South Sudan, and the use of rapid diagnostic tests in the field.
News • Herpes zoster
Shingles doubles stroke risk for several years
The study by researchers from the Department of Neurology at the University of Ulsan College of Medicine in Seoul showed that herpes zoster infection not only raised the risk of ischaemic and haemorrhagic stroke but also that of a transient ischaemic attack (TIA), a warning mini-stroke often preceding a full-blown stroke.
Article • Politics
Medics urged to organise refugee screening
Thousands upon thousands of humans have taken and are continuing to take flight from wars, persecution and economic stress, seeking the chance of survival in European and other countries. They arrive not only physically exhausted, but also in mourning for those killed in their own countries, or during hellish journeys – therefore many also suffer unimaginable mental traumas. Clearly they need…
News • EADV Symposium
Dermatologists and Venereologists discuss refugee crisis
The 13th Symposium of the European Academy of Dermatology and Venereology, which opened its doors last Thursday 19th May and took place in Athens, Greece, came to a conclusion yesterday, after more than 2,000 participants benefited from a series of scientific sessions focusing on the latest developments in Dermatology and Venereology.
Article • Mini Microscopes
Mobile technology could enhance digital pathology
Mobile technology could prove an important catalyst in helping take digital pathology onto a new level in delivering clinical diagnostics.
News • Bacteria
Revolutionary antibiotics will save the world
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
News • Looking inside
A new method of viewing TB bacteria
Although tuberculosis (TB) is commonly thought of as being a disease that mainly affects nineteenth century poets and Victor Hugo characters, it is still the second-most common cause of mortality from an infectious disease in the world, killing nearly three people every minute.
News • ECCMID 2016
Pioneering research abstracts on colistin resistance and migrant health
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risks, knowledge sharing and best practices in the fight against infectious disease – has received more than 300 late-breaker abstract submissions for its annual congress, ECCMID 2016 in Amsterdam.
Article • Refugees
The major healthcare challenge
The refugee wave rolls on with no ebb in sight. For many, Germany remains their travel destination. In August and September alone, tens of thousands refugees arrived in Munich, presenting the Bavarian capital with a major challenge: How could the city provide initial medical care for everyone? While the German Asylum Procedure Act governs the appropriate procedures, in this unprecedented…
New funding for Ebola hides an ongoing decline
A new report gives the first ever picture of global investment in Ebola research and development (R&D), reporting that this investment might have come at the expense of efforts to develop drugs, vaccines and diagnostics for other neglected diseases, which collectively cause more than six million deaths every year in developing countries.
Interview • Evolution
On the cusp of Medicine 4.0
In the world of technology, the term Industry 4.0 is already well known. Univ-Prof. Dr. rer. nat. Bernhard Wolf has reveals a comparable development in medicine. Smart systems and personalisation have enormous potential, the Professor for Medical Electronics at the Technical University of Munich is convinced.
Article • Infectious diseases
Developing vaccines and nanotechnology
Vaccination remains one of the most efficient strategies against infectious diseases, often being the best protection against infections such as hepatitis B, or influenza. European Hospital reports on expert reviews of vaccines in the pipeline and the potential of nanomedicine given during the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) annual meeting in…
News • Aspergillus
ESCMID cautions that Europe is now a hotbed of global fungal resistance
ESCMID Fungal Infection Study Group (EFISG) argues that fungal resistance now represents a huge healthcare threat – with many cases remaining massively undiagnosed even in the developed world – and that there is a rising prevalence of the most invasive and deadly forms. Conversely, in the developing world we are seeing very treatable fungal infections killing huge numbers – half a million…
Article • Politics
Antibiotic resistance is a threat to global health
Within 15 years effective antibiotics will run out and, far from being an apocalyptic fantasy, a world in which common infections and minor injuries can kill is a very real possibility for the 21st Century. Geoff Sussman, one of the world’s foremost wound experts has warned that antibiotic resistance is posing the biggest single threat to global health. Report: Mark Nicholls
Test could identify resistant tuberculosis faster
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a team at University College London (UCL). This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Article • Preamble
Keeping up with an ever-evolving science
Expecting 10,000 participants, prior to the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark (25-28 April) its Programme Director, Professor Winfried V Kern MD, was keen to point out: ‘The findings and recommendations that emerge from this vibrant platform each year have, in the past, had a tremendous impact not only on guidelines and best…
News • New guidance
Contact precautions for hospital visitors
Leading infectious diseases experts have released new guidance for healthcare facilities looking to establish precautions for visitors of patients with infectious diseases. The guidance looks to reduce the potential for healthcare visitors in spreading dangerous bacteria within the healthcare facility and community. The recommendations are published online in Infection Control & Hospital…
Article • Cold plasma
Treatment out of a power socket
Electricity is not the only thing that should come out of an electrical socket; ideally so should cold atmospheric plasma, according to Dr Georg Daeschlein, at the Dermatology Department, University of Greifswald, who has investigated its medical properties for years. Report: Ralf Mateblowski
News • Fighting Infection
WHO joins ESCMID to fight global infections
The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (April 24th, 2015). This year’s event sees the European society exploring vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.
New antibiotic shows promise in treating drug-resistant bacteria
Scientists have discovered a new antibiotic, teixobactin, that can kill serious infections in mice without encountering any detectable resistance, offering a potential new way to get ahead of dangerous evolving superbugs.
Innovation: UK hand-held device could challenge ELISA’s position
UK scientists are developing a hand-held testing device for use at the point of care and provide a disease diagnosis on the same day.
Air trapping and variations in ventilation
Imaging procedures are rarely used to diagnose and treat asthma – but this may well change in the future.
Redefining diagnostics
New molecular technologies to screen drug-resistant TB are replacing, for example, culture-based tests that are slow, require experienced personnel, and need stringent microbiological safety precautions.
Same-day diagnosis from hand-held device
Scientists in the UK are working to develop a hand-held testing device to provide same day diagnosis from a patient’s bedside. The device will use disposable cartridges and utilise printed circuit board technology (PCB) that will allow a fast and low-cost diagnosis.
Spain’s huge public health deficit
The Spanish National Health System is organised following the principles of universal coverage and solidarity, to ensure equal access to healthcare services for all citizens.
Tiny tools, big effects
imec, the European research centre for nanoelectronics, has linked with Johns Hopkins University in Baltimore, USA, to develop the next generation of highly miniaturised medical tools.
Fighting tuberculosis in Russia remains a challenge
Approximately 1.7 billion people worldwide carry Mycobacterium tuberculosis (MTB), i.e. about one-third of the population. The rate of new infections is highest in Africa, followed by certain Asian regions, including areas in Russia.
The Robert Koch Foundation announces the 2013 laureates
Robert Koch Award 2013 goes to Jeffrey I. Gordon for pioneering studies of the human microbiome; Anthony S. Fauci receives the Robert Koch Gold Medal 2013 for outstanding scientific contributions to HIV research
Simpler risk scoring
Bioelectrical impedance analysis (BIA) supports physicians in vital treatment decisions.
We‘ll have highly personalised avatars
Petabytes of data on each patient will become the foundation of future diagnostics and therapy. Genetics, imaging and environmental information – toxins, lifestyle – will deliver a precise picture of the individual, allowing for diagnostic precision and targeted treatments.
We‘ll have highly personalised avatars
Petabytes of data on each patient will become the foundation of future diagnostics and therapy.
Nobel Prize awarded to Robert Koch Foundation Laureate
The Robert Koch Foundation congratulates Professor Shinya Yamanaka, the 2008 Robert Koch Award laureate, on being awarded this year’s Nobel Prize in Physiology or Medicine. The award to Yamanaka brings the number of Robert Koch Foundation laureates to receive a Nobel Prize to 11 since 1962.
Tangible Return on EU Investment in Global Health R&D
At the launch of the Policy Cures study ‘Saving Lives and Creating Impact: EU Investment in Poverty-Related and Neglected Diseases’ in Brussels today, DSW (Deutsche Stiftung Weltbevoelkerung) confirmed that EU funding for Global Health Research and Development (R&D) has a direct benefit on both developing countries and the European Union.
Don’t be complacent With few experts, we need to raise awareness about TB
With few experts, we need to raise awareness among physicians and undertake research to upgrade our knowledge of this disease
System identifies more pathogens and antimicrobial resistances than any other
By integrating all necessary pre-analytical and analytical steps into one solution, the recently CE-marked Unyvero system, which is now commercially available in Europe, provides pathogen identification and antibiotic resistance marker information without needing expert staff and a sophisticated infrastructure, its manufacturer Curetis reports. Of even greater interest is its range of targets.
Drug-resistant tuberculosis fuels need for faster testing & development of new combination therapies
Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with TB, and now at risk for this form of the highly contagious lung disease.
Growing presence of drug-resistant tuberculosis
Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with TB, and now at risk for this form of the highly contagious lung disease.
Sepsis – a Global Medical Emergency
The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. “Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care,” said Konrad Reinhart, M.D., Chairman of the GSA and director of the…
Childhood TB: Decreasing and rising in the EU and EEA
Although the overall rates of childhood tuberculosis (TB) are decreasing in the European Union (EU) and the European Economic Area (EEA), childhood TB is actually rising in certain countries.
MRSA - Keeping up with the neighbours
The border between Germany and the Netherlands in the so-called EUREGIO region is of no particular importance in the daily life of the people who live there. Every day, thousands commute between towns and cities in both countries, to work, shop or even receive medical treatment. The latter, however, presents Dutch hospitals with a problem.
New children's medicine guide released by UNICEF and WHO
An estimated 9 million children die each year from preventable and treatable causes. A new publication that lists medicines formulated for children is being made available now online by UNICEF and the World Health Organization, to help doctors and organizations obtain some of the 240 essential medicines that can save the lives of children.
The two faces of HIV/AIDS in the brain
The Opening Lecture at ECR always draws immense attention. On March 4th, it was the “First Lady of Radiology” as Congress President M. Szczerbo-Trojanowska called her, Professor Dr Anne G. Osborn, University of Utah, USA, who opened the event. The internationally renowned doctor of diagnostic neuroradiology spoke about “The two faces of HIV/AIDS in the brain” – a matter close to her…
Communicable disease programmes in Europe
One of the main topics at Health Forum Gastein 2009 was the way in which various healthcare systems struggle to cope with communicable diseases and their prevention. During the event, Dr Hans Kluge, Head of the Country Policies and Systems Unit, at the WHO regional office for Europe, spoke with Meike Lerner about omnipresent factors that work against effective TB and HIV/AIDS prevention…
Controlling infectious diseases in north-east Europe
Several years ago the Partners of the Northern Dimension Partnership in Public Health and Social Well-being (NDPHS) was organised to serve the Baltic Sea region. Due to the very different levels of public healthcare systems in north-east European countries, the NDPHS decided its main mission is to reduce social and economic differences and improve quality of life and demographic issues.
European Practice Assessment wins Health Award 2009
The "European Health Award" presented this year at the European Health Forum Gastein (EHFG) goes to the European Patient Assessment (EPA) project. EPA is designed to improve the exchange of knowledge and experience by practical physicians in the area of primary care. Cross-border healthcare initiatives are distinguished every year with the European Health Award.
Threat of communicable diseases to become worse
The threat of communicable diseases will become even worse in the near future. At the European Health Forum Gastein, the European Union's leading health policy congress for experts and decision-makers, experts stressed that there are a number of risk factors which contribute to a growing risk of the spread of communicable diseases into Europe, namely into the European Union.
Positive action in the war against MRSA
The first strain of methicillin resistant Staphylococcus Aureus (MRSA) was isolated in the 1960s, and its presence was reported worldwide in the late 1990s. A higher incidence of MRSA was noted in communities, at the dawn of the new millennium, leading to two basic MRSA strains being differentiated - CA-MRSA (community acquired MRSA) and HA-MRSA (healthcare associated MRSA). In clinical practice…
International TB support from KfW Development Bank
Within the World Health Organisation European region three quarters of all new tuberculosis (TB) infections occur in Kazakhstan, Romania, Russia, Uzbekistan, the Ukraine and Turkey. The multi-resistant TB viruses, which can no longer be treated with conventional medication, are particularly common there.
Delivering leading edge diagnostic tools to developing markets
Basic diagnostic x-ray services are a key component of primary health care delivery. However, two-thirds of the world's population is without access to it, according to World Health Organization (WHO) estimates. The WHO further estimates that there is a need for one diagnostic imaging machine for every 50,000 people. The World Health Imaging Alliance announced that it has cemented key…
GE's new Discovery PET/CT 600 scanners go global
GE Healthcare's first Discovery PET/CT 600-series scanners are being installed in a number of leading clinics around the world. "This first set of installations is a big step forward in the diagnosis and monitoring of disease", said Terri Bresenham, newly appointed vice- president and general manager of GE Healthcare's global Molecular Imaging business.
Healthcare sector to fight ATB over-consumption
Czech hospitals are seeking powerful inspiration regarding antibiotics (ATB) consumption from France, where a recent public campaign helped to decrease ATB consumption by 30%.
Drug resistant tuberculosis test within hours
GenoType® MTBDR plus, a new molecular test for multidrug-resistant tuberculosis has recently been approved in Europe. The test, developed by the Foundation for Innovative New Diagnostics (FIND) and Hain Lifescience, offers a fast solution to detect MDR-TB and XDR-TB at a reasonable price, a good condition for the application in poorer countries.
Gleam of hope for people living with HIV
The “Project Connect”, a program designed to build Public Private Partnerships to combat HIV and tuberculosis in India recently recorded a huge success:
ESCAIDE 2008
For the second time the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, invites to the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE). The ECDC published now a forecast about expectations and the global hot topics of the international event in Berlin, November 19-21.
Awards for TB study organisation
In 2005, former German Chancellor Schröder and Russian President Putin agreed on a strategic partnership to give infectious disease control the highest priority.
WMA gains funding to support TB training course
Pharma company Eli Lilly has increased an existing partnership with the World Medical Association (WMA) by granting c. 646,505 euros to expand online training courses for physicians on multi-drug resistant tuberculosis (MDR-TB), which they have been developed over the past year.
India's world experts on TB
Every three minutes, two people living in India die of tuberculosis. This equates to approximately 370,000 deaths each year, and a staggering economic toll: an estimated US$300 million in direct costs and US$3 billion in indirect costs.
Nurses receive award for their work in tuberculosis
By putting the World TB Day slogan 'I am stopping TB' into action, 11 nurses have earned the 2008 ICN/Lilly Award, for their outstanding work in fighting tuberculosis (TB) and multi-drug resistant TB (MDR-TB)[1]. The award recipients come from six TB affected countries: from Kenya (Diana Jelegat Kipsoisoi), Lesotho (Likhapha Ntlamelle ), Malawi (Chrisie Bwazi, Rodwell Gundo and Shouts Simeza),…
The Berlin TB Symposium
The WHO-Euro region ranges from Portugal to the East Asian parts of Russia, including Central Asia and the Southern Caucasus. Because of the increasing numbers of tuberculosis and rates of multidrug resistance (MDR TB), tuberculosis was declared a regional emergency in 2004.
Inhaled TB vaccine
USA - A new tuberculosis vaccine successfully tested at the University of North Carolina (UNC) is easier to administer and store and just as effective as one commonly used worldwide, according to research published in the Proceedings of the National Academy of Sciences.
Alarming TB cases in Austria
A third of the worlds population is infected with the bacterium Myobacterium tuberculosis which infects around nine million people annually.
The high profile agenda of Europe's biggest radiology congress
The 2008 ECR promises to be international, controversial, inspiring, as well as a meeting in which new insights for inter-professional relationships and working practices are sought. The programme is impressive indeed.
analytica 2008
Analytica, to be held in Munich for the 21st time, has become a leading international trade fair for instrumental analysis, laboratory technology and biotechnology, showcasing the entire range of equipment, solutions and services for laboratories in industry and research. About 400 exhibitors will fill five halls in the New Munich Trade Fair Centre.
Tracking TB bacterium from space
TB bacterium have a unique chemical coating and it is hoped that a tiny gas chromatograph mass spectrometer (GC-MS) - a detection device* developed for the Beagle 2, on its mission to Mars - will be able to pick this out from space, in a project run by Britain's Open University and the London School of Hygiene and Tropical Medicine.
Setting international standards for TB care
By Professor Giovanni Battista Migliori MD, Director of the WHO Collaborating Centre for Control of Tuberculosis and Lung Diseases.
analytica comes of age
21st. Analytica 2008 held in april 2008 in Munich, Germany.
Virtual TB bacillus should help finding new drugs
Today little is known about the metabolism of the tuberculosis bacillus and, because of its slow growth, experiments for new drugs take a long time. Now a team of researchers form the University of Surrey built an in silico model of the agent that causes TB - a virtual TB bacillus - that promises to speed up the drug discovery process.
Screenings beneficial in common tuberculosis areas
In areas of the UK where tuberculosis has a high prevalence, screenings could increase diagnosis both of active and latent forms of the disease and therefore could help prevent its spread.
A 'World Health Insurance'
In a recently published article, a team from Médecines Sans Frontières have suggested a 'World Health Insurance' to help provide healthcare for people in poorer nations (see box). Over 50% of the 42 countries carrying that healthcare burden would be European.
Slovakia
Slovakia was part of the Austrian-Hungarian Empire until 1918, when Czechs and Slovaks were brought together to form the Czechoslovak Republic. After World War II, and up to 1948, the country was still part of Europe, but then fell behind the 'Iron Curtain'. From 1989 it began 'knocking on the EU door' and entry was granted in 2003. Today Slovakia's population is around 5.38 million. To serve…
Help for the helpers
Healthcare systems in Africa are facing a huge threat in their fight against AIDS - an increasing shortfall of nursing staff. Workers are either infected themselves or can no longer cope with the daily fight against the disease. Despite this, there is hope - the first wellness centre for healthcare workers, which provides medical and psychological help to nursing staff and their families, was…
TB - Tuberculosis
Discovery of cell receptor CCR5 might help tackle TB.
European Respiratory Society Congress
`Respiratory diseases are still a huge burden for our countries,´ Giovanni Viegi, President of the European Respiratory Society pointed out at the congress.
Respiratory diseases
From burden to therapy. By Andrea Rossi MD, Director of the Respiratory Division at Bergamo General Hospital Bergamo, Italy, and Chair of the Scientific Committee of the European Respiratory Society
Tuberculosis blood test gains EU approval
TB causes three million deaths annually, ranking it higher than any other infectious disease. And TB has resurged in Europe. In August, the British Thoracic Society, British Lung Foundation and TB Alert highlighted its increase in over the last 15 years in the UK alone.
